According to cancer staging, in the TCGA dataset, FN mRNA expression level was overall significantly increased among breast cancer patients with different stages compared to normal tissues, with higher levels in stage II (P < 0.0001) and III (P < 0.05) than in stage I according to METABRIC dataset (Fig. 8B). This evidence concerns the gene FN1 and breast cancer.